U.S. Markets closed

Orexigen Therapeutics, Inc. (OREX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.97+0.03 (+1.02%)
At close: 4:00PM EDT
People also watch
VVUSARNAKERXMNKDACHN
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2017)Next Qtr. (Jun 2017)Current Year (2017)Next Year (2018)
No. of AnalystsN/AN/A11
Avg. EstimateN/AN/A-8.55-5.14
Low EstimateN/AN/A-8.55-5.14
High EstimateN/AN/A-8.55-5.14
Year Ago EPS-1.5-2.53-9.75-8.55
Revenue EstimateCurrent Qtr. (Mar 2017)Next Qtr. (Jun 2017)Current Year (2017)Next Year (2018)
No. of Analysts1122
Avg. Estimate19.14M20M82.4M120.9M
Low Estimate20M20M79M90M
High Estimate20M20M85.8M151.8M
Year Ago Sales5.03M7.79M33.71M82.4M
Sales Growth (year/est)280.40%156.70%144.40%46.70%
Earnings History3/30/20166/29/20169/29/201612/30/2016
EPS Est.-1.7-1.47-2.24-1.18
EPS Actual-1.5-2.53-2.06-3.2
Difference0.2-1.060.18-2.02
Surprise %11.80%-72.10%8.00%-171.20%
EPS TrendCurrent Qtr. (Mar 2017)Next Qtr. (Jun 2017)Current Year (2017)Next Year (2018)
Current EstimateN/AN/A-8.55-5.14
7 Days Ago-0.84-0.82-8.55-5.14
30 Days Ago-0.84-0.82-8.55-5.14
60 Days Ago-0.84-0.82-6.72-1.85
90 Days Ago-0.84-0.82-6.72-1.85
EPS RevisionsCurrent Qtr. (Mar 2017)Next Qtr. (Jun 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesOREXIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.20
Next Qtr.N/AN/AN/A0.21
Current Year12.30%N/AN/A0.09
Next Year39.90%N/AN/A0.12
Next 5 Years (per annum)-78.50%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A